Oxycodone Withdrawal: Symptoms, Course and What Shifts It

Oxycodone withdrawal begins when a body that has adapted to the drug stops getting it. MedlinePlus publishes the symptom list under oxycodone’s own name, and its first instruction is the one people skip: anyone taking oxycodone regularly is told not to stop it, or bring it down quickly, without talking to their doctor first [5]. Its next line is the one a prescribed reader needs: the doctor will probably decrease the dose gradually [5].

Nobody publishes an hour-by-hour clock for this drug, and this page will not invent one. SAMHSA gives withdrawal figures per drug rather than for opioids as a class, and it has no oxycodone row [1]. The World Health Organization’s withdrawal-management guidance gives a window for short-acting opioids as a group — it does not mention oxycodone anywhere [2]. So what follows is the class window, named as the class window, plus what is published about this drug specifically.

This page has no schedule to follow and no amounts, because the decisions that govern a withdrawal belong to a clinician with your history in front of them. For background on the drug itself, see our page on oxycodone.

What the Published Windows Actually Say, and Do Not Say

Three things are published. It is worth keeping them apart.

One: the rule, not a number. SAMHSA states that all opioid agents produce similar withdrawal signs and symptoms, with some variance in severity, time of onset and duration, depending on the agent used, the duration of use, the daily dose and the interval between doses [1]. The clock belongs to the drug and the pattern of use. It does not belong to opioids as a group.

Two: a class window, from the WHO. Its 2009 clinical guidelines for closed settings put the onset of opioid withdrawal symptoms at 8 to 24 hours after last use for short-acting opioids, with a duration of 4 to 10 days [2]. Read the scope carefully. That is a figure for a class, the chapter’s own example of the class is heroin, and the word “oxycodone” does not appear in the chapter at all. Oxycodone belongs in that group on its pharmacology rather than because the guidance names it: its plasma half-life is 3 to 5 hours, and an immediate-release form acts for about 3 to 6 hours against about 12 hours for a controlled-release one [6].

Three: an earliest edge, from NIDA. People who stop an opioid medication can have severe withdrawal symptoms that begin as early as a few hours after the drug was last taken [4]. “Can” and “as early as” are NIDA’s own words.

What is not published anywhere this page could reach: an oxycodone-specific onset, an oxycodone-specific peak day, or an oxycodone-specific duration. That is a statement about five documents read in full for this page in September 2026 — SAMHSA’s TIP 45 Chapter 4, the WHO chapter, NIDA’s Drugs A to Z, NIDA’s Prescription Opioids DrugFacts and MedlinePlus’s oxycodone drug page — and it means the figure was not found there, not that no such figure exists anywhere. It is still why the stages below are described rather than dated.

The First Hours: A Few Hours to 8 Hours In

Nothing dramatic usually happens at first, and the lull misleads people.

Symptoms can begin as early as a few hours after the last use [4], while the WHO window for short-acting opioids opens at 8 hours [2]. The earliest signs are the autonomic ones. A runny nose. Watering eyes. Yawning. Sweating. Gooseflesh. Restlessness and anxiety arrive alongside them, and the WHO lists anxiety, insomnia, hot and cold flushes, perspiration and watery discharge from the eyes and nose among the symptoms of opioid withdrawal [2].

Sleep generally goes first and it tends to stay gone longest. MedlinePlus lists difficulty falling asleep or staying asleep in its oxycodone withdrawal list [5], and NIDA lists insomnia in its oxycodone entry [3].

This is the point where a decision is still easy to make and a phone call is still easy to place. It gets harder later, which is the practical reason for making the call early rather than waiting to see how bad it gets.

The Hardest Stretch, and Why No Source Names a Peak Day

This is where most attempts at stopping alone end.

NIDA’s own entry for oxycodone lists the withdrawal symptoms as muscle and bone pain, cold flashes with goose bumps, cramps, diarrhea, involuntary leg movements, restlessness, vomiting and insomnia [3]. MedlinePlus’s oxycodone list adds muscle or joint aches, weakness, irritability, anxiety, depression, loss of appetite, a fast heartbeat and rapid breathing [5]. The WHO adds nausea and muscle cramps to the same picture [2].

No source read for this page names a peak day for oxycodone. What SAMHSA describes is the arc rather than the hour: untreated opioid withdrawal gradually builds in severity of signs and symptoms, and then diminishes in a self-limited manner [1]. It builds, it turns, it settles. That is the honest version of “which day is worst”, and it is more useful than a number that may not match what is happening to you.

The physical picture is exhausting rather than dangerous. What makes it risky is the combination: severe discomfort, poor sleep, fluid loss from vomiting and diarrhea, and craving at its strongest. SAMHSA notes that severe gastrointestinal symptoms can rarely lead to dehydration or electrolyte imbalance, and that existing cardiac illness can be made worse by the raised blood pressure, pulse and sweating that come with opioid withdrawal [1].

In a clinical setting this is the phase where medication does the most work. NIDA names lofexidine as an FDA-approved medication to reduce opioid withdrawal symptoms [3]. What is used, and whether it is used at all, is a prescriber’s decision.

As the Acute Window Closes

The acute physical symptoms fade across the back half of the class window for most people. The WHO window for short-acting opioids runs to a maximum of about 10 days [2], so a tail through the end of the first week is ordinary rather than a sign something has gone wrong.

What tends to remain: poor sleep, low energy, aching, a flat or irritable mood, and appetite that has not come back.

This is the phase people underestimate, because from the outside someone looks like they are through it. They are through the visible part. Cravings are often at their most dangerous here, precisely because the acute misery that was occupying all the attention has lifted.

It is also the point where a plan either exists or does not. If the only plan was to get through withdrawal, this is where it runs out.

If someone is having a seizure, is unresponsive or has trouble breathing, call 911. For a mental health crisis, call or text 988.

Week Two and Beyond

The acute window for short-acting opioids closes at around 10 days [2]. What comes after it is a different kind of difficulty, and the WHO describes it directly: a protracted phase that can last up to six months, marked by a general feeling of reduced well-being and strong cravings for opioids, with the craving often leading back to use [2].

Sleep often stays disturbed for weeks. Mood can be flat, motivation low, and ordinary pleasures muted. Cravings become intermittent rather than constant, and they tend to attach to particular places, times of day or people.

Two things are worth knowing here.

First, this phase is why medication for opioid use disorder exists. NIDA states that methadone, buprenorphine and naltrexone are all FDA-approved medications to treat opioid use disorder [3], and describes naltrexone as an antagonist that prevents opioids from attaching to opioid receptors [4]. Those medications address the period after withdrawal, not the withdrawal itself.

Second, the overdose risk. The WHO advises that everyone who has withdrawn from opioids is at increased risk of overdose because their tolerance has fallen [2]. MedlinePlus states the mechanism in one sentence anyone can open and check: withdrawal reduces the person’s tolerance to the medicine, so those who have just gone through withdrawal can overdose on a much smaller dose than they used to take, and most opioid overdose deaths occur in people who have just detoxed [7]. That is the strongest single argument against treating a withdrawal as a standalone achievement.

If someone is having a seizure, is unresponsive or has trouble breathing, call 911. For a mental health crisis, call or text 988.

Our page on medication-assisted treatment sets out how those options work, and our guide to withdrawal symptoms covers the broader picture.

What Changes the Course

Five things move it, and none of them is something a person can adjust on the day.

How much, and for how long. SAMHSA names the duration of use, the daily dose and the interval between doses among the factors that change severity, onset and duration [1]. NIDA describes dependence as repeated use causing neurons to adapt so that they only function normally in the presence of the drug [4].

Which formulation. An immediate-release form of oxycodone acts for about 3 to 6 hours; a controlled-release form lasts about 12 hours [6]. That changes when withdrawal starts, and it is why the same person can have a different first day on a different product.

Liver and kidney function. Oxycodone is metabolized by the hepatic enzymes CYP3A4 and CYP2D6, and its metabolites are cleared by the kidneys [6]. Impairment at either point slows everything down.

Other substances. Alcohol and benzodiazepines change the picture substantially, and both have withdrawal syndromes of their own that can be dangerous in ways opioid withdrawal is not [1]. The WHO describes withdrawal management as medical and psychological care, and says healthcare workers should be available 24 hours a day [2].

Physical and mental health, and pregnancy. SAMHSA notes that anxiety disorders, panic anxiety in particular, may become more intense during opioid withdrawal, and that any condition involving pain is likely to worsen because the pain threshold drops and the relief the opioid was giving is gone [1]. Pregnancy changes the plan entirely: the WHO recommends that pregnant women who are opioid dependent do not undergo opioid withdrawal, because it can cause miscarriage or premature delivery, and that methadone maintenance is the recommended approach instead [2].

This is precisely the list a clinician works through at assessment, which is why an accurate history matters more than a stoic one.

Why a Supervised Setting Changes It

Supervision does three things that cannot be replicated at home.

It manages symptoms with medication, under someone watching the trend rather than a single moment. The WHO’s own standard is that patients should be monitored regularly, three to four times daily, for symptoms and complications [2], and SAMHSA says repeated assessments should be made during detoxification to determine whether symptoms are improving or worsening and whether the medication being used is working [1].

It catches complications. Dehydration. An unstable heart condition. An unrecognized second withdrawal syndrome from alcohol or benzodiazepines. These are the things that turn an unpleasant week into an emergency.

And it removes the availability problem. The hardest moment in an opioid withdrawal is not the physical peak. It is the moment on the second day when stopping the discomfort is a single phone call away.

The WHO is blunt about what withdrawal management is for. It is unrealistic to think it will lead to sustained abstinence on its own; it is an important first step before a patient commences psychosocial treatment [2]. Our explainer on medical detox covers what a supervised withdrawal involves, and our guides to inpatient rehab and levels of care cover the settings.

What Happens After Withdrawal

Treatment starts. That is the whole answer, and it is the part most often skipped.

NIDA’s position on opioids is unusually direct. When treating addiction to opioids, medication should be the first line of treatment, usually combined with some form of behavioral therapy or counseling [8]. It names the behavioral half in its own words: cognitive-behavioral therapy helps people recognize, avoid and cope with the situations in which they are most likely to use drugs; contingency management uses rewards or privileges for staying drug-free, for attending counseling, or for taking treatment medications as prescribed; and motivational enhancement therapy makes the most of somebody’s readiness to change and enter treatment [8]. NIDA also states the consequence of stopping at the withdrawal stage: detoxification alone without subsequent treatment generally leads to resumption of drug use [8].

In practice that means a level of care after the withdrawal stage — residential treatment, a partial hospitalization program, or intensive outpatient care, with medication and therapy running through it. Our pages on outpatient rehab and how long rehab takes cover what to expect.

Settle one question before discharge: who prescribes the medication next, and when the first appointment is. A prescription that lapses in the week after a withdrawal is the most common preventable failure in this whole sequence.

On cost, the Mental Health Parity and Addiction Equity Act means a plan that covers mental health and substance use care may not apply harsher limits to it than it applies to medical and surgical care, and that reaches prior authorization as well as visit and day caps [9]. The scope is worth knowing: it applies to non-federal governmental plans with more than 50 employees, to group health plans of private employers with more than 50 employees, and to the individual market [9]. Plans from small employers are not covered directly; they get comparable protection through the Affordable Care Act’s essential health benefits requirement. See our pages on insurance coverage and what rehab costs, our admissions walkthrough, and our directory of treatment centers.

Frequently Asked Questions

Sources

1. Center for Substance Abuse Treatment. (2006). Detoxification and Substance Abuse Treatment, Chapter 4: Physical Detoxification Services for Withdrawal From Specific Substances — Opioids. Substance Abuse and Mental Health Services Administration. https://www.ncbi.nlm.nih.gov/books/NBK64116/
2. World Health Organization. (2009). Clinical Guidelines for Withdrawal Management and Treatment of Drug Dependence in Closed Settings, Chapter 4: Withdrawal Management. NCBI Bookshelf. https://www.ncbi.nlm.nih.gov/books/NBK310652/
3. National Institute on Drug Abuse. Drugs A to Z — Oxycodone. National Institute on Drug Abuse. https://nida.nih.gov/research-topics/drugs-a-to-z
4. National Institute on Drug Abuse. Prescription Opioids DrugFacts. National Institute on Drug Abuse. https://nida.nih.gov/publications/drugfacts/prescription-opioids
5. U.S. National Library of Medicine. Oxycodone. MedlinePlus Drug Information. https://medlineplus.gov/druginfo/meds/a682132.html
6. Sadiq NM, Dice TJ, Mead T. Oxycodone. StatPearls, NCBI Bookshelf, National Library of Medicine. https://www.ncbi.nlm.nih.gov/books/NBK482226/
7. U.S. National Library of Medicine. Opiate and Opioid Withdrawal. MedlinePlus Medical Encyclopedia. https://medlineplus.gov/ency/article/000949.htm
8. National Institute on Drug Abuse. (2020). Drugs, Brains, and Behavior: The Science of Addiction — Treatment and Recovery. National Institute on Drug Abuse. https://nida.nih.gov/publications/drugs-brains-behavior-science-addiction/treatment-recovery
9. Centers for Medicare and Medicaid Services. The Mental Health Parity and Addiction Equity Act (MHPAEA). Centers for Medicare and Medicaid Services. https://www.cms.gov/marketplace/private-health-insurance/mental-health-parity-addiction-equity

This page is for general information and is not medical advice. Only a licensed clinician who knows your history can tell you what is right for you. If you or someone you know is in immediate danger, call 911. For free, confidential support 24/7, call or text 988.

Author

Kevin Wandler, MD

Chief Medical Officer, The Recovery Village